GSK Receives Priority Status For New HIV Wonder Drug
The experimental drug for HIV/AIDS by British pharmaceutical company, GlaxoSmithkline (GSK) referred to as dolutegravir has received priority status by the United States Food and Drug Administration.Drugs are given priory status when…